Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Current Value
$21.691 Year Return
Current Value
$21.691 Year Return
Market Cap
$12.97B
P/E Ratio
18.15
1Y Stock Return
12.47%
1Y Revenue Growth
0.42%
Dividend Yield
2.13%
Price to Book
0.9
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ORLY | -<0.01% | $69.31B | +22.06% | 0.00% |
RGA | -0.02% | $14.97B | +41.90% | 1.52% |
ABEO | 0.08% | $256.04M | +41.25% | 0.00% |
POAI | -0.13% | $4.29M | -78.60% | 0.00% |
YPF | -0.15% | $13.98B | +139.72% | 0.00% |
ARQ | -0.15% | $332.89M | +216.80% | 0.00% |
QNTM | -0.22% | $9.19M | -94.36% | 0.00% |
CW | -0.26% | $13.73B | +70.49% | 0.23% |
RSG | 0.26% | $66.05B | +31.79% | 1.04% |
RLMD | 0.29% | $89.92M | +1.36% | 0.00% |
OKLO | 0.31% | $2.66B | +111.04% | 0.00% |
CRVO | 0.34% | $83.20M | +2.86% | 0.00% |
BMA | 0.40% | $5.08B | +232.03% | 6.53% |
CME | -0.45% | $82.76B | +9.21% | 1.98% |
OCFT | -0.46% | $80.95M | -30.38% | 0.00% |
DNTH | -0.54% | $659.13M | +93.65% | 0.00% |
FUN | 0.55% | $4.60B | -16.51% | 0.00% |
LUNA | -0.57% | $55.69M | -71.48% | 0.00% |
WMT | 0.58% | $696.11B | +66.69% | 1.38% |
AMGN | -0.61% | $150.48B | +6.52% | 3.20% |
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DVA | 54.63% | $12.87B | +60.92% | 0.00% |
THC | 40.08% | $14.58B | +131.72% | 0.00% |
COTY | 36.85% | $6.17B | -34.71% | 0.00% |
KIDS | 36.82% | $588.93M | -24.59% | 0.00% |
OFG | 36.61% | $1.99B | +30.61% | 2.23% |
SLG | 36.28% | $5.09B | +133.31% | 3.89% |
FNB | 36.01% | $5.89B | +40.69% | 2.94% |
BYON | 35.91% | $283.64M | -61.81% | 0.00% |
IBOC | 35.91% | $4.40B | +55.95% | 1.88% |
BANF | 35.82% | $4.02B | +41.10% | 1.44% |
FCF | 35.81% | $1.89B | +40.91% | 2.77% |
SSB | 35.67% | $8.02B | +43.60% | 2.02% |
SGRY | 35.66% | $2.89B | -28.97% | 0.00% |
NMRK | 35.57% | $2.60B | +94.74% | 0.79% |
CBU | 35.44% | $3.59B | +52.15% | 2.67% |
STWD | 35.35% | $6.66B | +0.36% | 9.76% |
SNN | 35.33% | $11.12B | -0.04% | 2.98% |
FFBC | 35.31% | $2.75B | +42.24% | 3.23% |
BAX | 35.15% | $16.60B | -8.91% | 3.57% |
PDM | 35.09% | $1.17B | +53.51% | 5.34% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TPST | -47.88% | $37.75M | -77.59% | 0.00% |
MCK | -17.97% | $78.15B | +35.51% | 0.42% |
COKE | -14.33% | $10.72B | +73.12% | 0.33% |
RDDT | -12.20% | $24.08B | +303.41% | 0.00% |
RNR | -12.03% | $13.74B | +23.09% | 0.58% |
GRMN | -11.86% | $39.82B | +73.79% | 1.43% |
QNRX | -11.40% | $3.20M | -85.07% | 0.00% |
MNR | -10.99% | $1.66B | -10.71% | 15.90% |
HUSA | -10.30% | $16.69M | -11.56% | 0.00% |
XBIO | -10.06% | $6.01M | +21.36% | 0.00% |
COR | -9.98% | $47.48B | +21.20% | 0.86% |
CYD | -9.97% | $364.46M | -2.94% | 4.26% |
IMNN | -9.82% | $10.02M | -22.89% | 0.00% |
EVER | -9.36% | $664.25M | +124.76% | 0.00% |
CBOE | -9.27% | $21.46B | +15.84% | 1.11% |
LFWD | -9.13% | $16.21M | -63.99% | 0.00% |
CANG | -9.08% | $253.50M | +212.50% | 0.00% |
SMC | -9.07% | $383.35M | +97.26% | 0.00% |
EXEL | -8.89% | $9.83B | +62.16% | 0.00% |
XOS | -8.60% | $30.51M | -57.24% | 0.00% |
Yahoo
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced its heart and lung group has been awarded a national group purchasing agreement for Mechanical Circulatory Support with Premier, Inc in the U.S. Since acquiring Xenios in 2016, Fresenius Medical Care has been dedicated to advancing heart and lung therapy. The agreement underscores FME's commitment to critical care solutions and allows Premier member hospitals a
SeekingAlpha
DaVitaâs strong services face risks from debt and economic uncertainties. Find out why DVA stock is a "Hold" with a $130 price target amid these challenges.
Yahoo
FMS' third-quarter results showcase a strong segmental performance. The company raises its full-year 2024 outlook for operating income.
Yahoo
Fresenius Medical Care (FMS) has released an update. Fresenius Medical Care reported robust growth in its operating income margin for Q3 2024, driven by organic revenue growth and improved U.S. dialysis treatment volumes. The company exceeded its FME25 savings target, achieving significant cost reductions, and further optimized its portfolio by divesting non-core assets. With a positive outlook, Fresenius continues to focus on enhancing operational performance and financial stability. For furthe
Yahoo
Fresenius Medical Care AG (FMS) reports improved operating income margins and significant savings, despite challenges in the US market and value-based care sector.
Yahoo
If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UUP | -24.27% | $309.25M | 0.77% |
USDU | -23.96% | $201.97M | 0.5% |
BTAL | -21.43% | $388.04M | 1.43% |
EQLS | -18.55% | $76.08M | 1% |
DBA | -15.56% | $755.88M | 0.93% |
VIXY | -15.32% | $195.31M | 0.85% |
CLOI | -11.72% | $715.40M | 0.4% |
DBE | -10.70% | $50.13M | 0.77% |
USCI | -10.28% | $185.47M | 1.07% |
CTA | -9.46% | $350.27M | 0.78% |
DBMF | -8.81% | $1.02B | 0.85% |
KCCA | -8.71% | $220.51M | 0.87% |
IBDP | -8.35% | $2.11B | 0.1% |
TBIL | -8.29% | $4.38B | 0.15% |
UNG | -8.27% | $908.80M | 1.06% |
KMLM | -3.50% | $353.87M | 0.9% |
BILZ | -2.94% | $563.02M | 0.14% |
SHYD | -2.85% | $311.50M | 0.35% |
TAIL | -2.30% | $67.98M | 0.59% |
BOXX | -2.10% | $4.43B | 0.1949% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MINT | -0.33% | $11.62B | 0.35% |
DBO | 0.38% | $217.57M | 0.77% |
GCC | 1.06% | $133.23M | 0.55% |
AGZD | -1.07% | $142.76M | 0.23% |
COMT | 1.32% | $829.06M | 0.48% |
JBBB | -1.33% | $1.26B | 0.49% |
HIGH | -1.62% | $302.78M | 0.51% |
PDBC | 1.68% | $4.40B | 0.59% |
BOXX | -2.10% | $4.43B | 0.1949% |
WEAT | 2.10% | $120.27M | 0.28% |
BTF | 2.30% | $51.69M | 1.24% |
TAIL | -2.30% | $67.98M | 0.59% |
DBC | 2.68% | $1.39B | 0.87% |
SHYD | -2.85% | $311.50M | 0.35% |
BILZ | -2.94% | $563.02M | 0.14% |
GSG | 3.03% | $914.42M | 0.75% |
DEFI | 3.14% | $13.58M | 0.94% |
KMLM | -3.50% | $353.87M | 0.9% |
BITO | 3.59% | $2.65B | 0.95% |
MUST | 3.70% | $410.00M | 0.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XHE | 40.34% | $213.41M | 0.35% |
IFGL | 39.82% | $93.00M | 0.54% |
SDIV | 39.36% | $779.09M | 0.58% |
CGW | 39.10% | $962.52M | 0.56% |
SRET | 38.61% | $212.57M | 0.59% |
FAN | 38.05% | $163.64M | 0.6% |
EWP | 37.81% | $917.06M | 0.5% |
FEP | 36.89% | $196.56M | 0.8% |
RWX | 36.76% | $253.63M | 0.59% |
GSIE | 36.66% | $3.55B | 0.25% |
DIVI | 36.54% | $968.44M | 0.09% |
IDLV | 36.24% | $252.07M | 0.25% |
IWN | 36.17% | $13.17B | 0.24% |
SMDV | 35.82% | $754.57M | 0.4% |
VBR | 35.79% | $32.03B | 0.07% |
DES | 35.78% | $2.13B | 0.38% |
VNQI | 35.77% | $3.29B | 0.12% |
RIET | 35.75% | $88.96M | 0.5% |
DFSV | 35.73% | $4.16B | 0.31% |
SPSM | 35.62% | $12.72B | 0.03% |